OneSource Specialty Pharma LimitedNSE: ONESOURCE

Press Release Jan 28 2025

· Issued by OneSource Specialty Pharma Limited

Filed with NSE · · 2 pages · English

Release

Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "OneSource receives EIR with 'Voluntary Action Indicated' classification from USFDA for its BLD Facility".

OneSource Specialty Pharma Limited on 6ix

In the deck

Later from OneSource Specialty Pharma

All OneSource Specialty Pharma news releases